CAMP4 THERAPEUTICS CORP CAMP
COM · Common Stock · CUSIP 13463J101
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersWatertown, MA
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $1.45.
Trends to Q2 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2024 | 37 |
| Q1 2025 | 40 |
| Q2 2025 | 30 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2025 | 18 | 13 |
| Q2 2025 | 13 | 28 |
Biggest buyers
| MILLENNIUM MANAGEMENT LLC | New | +133.0k |
| VANGUARD GROUP INC | Added | +95.1k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | New | +25.0k |
| Qube Research & Technologies Ltd | New | +14.9k |
| Verition Fund Management LLC | New | +14.8k |
| GOLDMAN SACHS GROUP INC | Added | +14.6k |
| CANTOR FITZGERALD, L. P. | New | +12.3k |
| Tower Research Capital LLC (TRC) | New | +3.8k |
| UBS Group AG | Added | +1.9k |
| ROYAL BANK OF CANADA | Added | +1.5k |
Biggest sellers
| FRANKLIN RESOURCES INC | Sold out | -635.1k |
| BlackRock, Inc. | Reduced | -212.0k |
| FMR LLC | Reduced | -159.0k |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | -84.4k |
| NORTHERN TRUST CORP | Reduced | -42.3k |
| STATE STREET CORP | Sold out | -26.2k |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | Sold out | -16.7k |
| Bank of New York Mellon Corp | Sold out | -13.1k |
| JPMORGAN CHASE & CO | Reduced | -8.0k |
| BARCLAYS PLC | Sold out | -7.5k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| JANUS HENDERSON GROUP PLC 13G · institution new · filed 2026-01-08 | 12.2% |
| Coastlands Capital LP 13G · institution no change · filed 2025-12-11 | 10.0% |
| 5AM Ventures VI, L.P. 13D · may seek influence no change · filed 2026-08-31 | 9.9% |
| FMR LLC 13G · institution +2.8 pts · filed 2026-02-05 | 9.5% |
| Vivo Opportunity Fund Holdings, L.P. 13G · passive investor -0.2 pts · filed 2026-02-13 | 7.4% |
| Polaris Management Co. VII, L.L.C. 13D · may seek influence -2.1 pts · filed 2026-08-19 | 6.3% |
| Trails Edge Capital Partners, LP 13G · passive investor new · filed 2026-08-10 | 6.0% |
Fell to 5% or below in the last year: BALYASNY ASSET MANAGEMENT L.P. (5.0%, 2026-08-14), Enavate Sciences GP, LLC (4.8%, 2026-03-11)
Insider purchases and sales in Q2 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2023 | 0 | — | 0 | — | — |
| Q4 2023 | 0 | — | 0 | — | — |
| Q1 2024 | 0 | — | 0 | — | — |
| Q2 2024 | 0 | — | 0 | — | — |
| Q3 2024 | 0 | — | 0 | — | — |
| Q4 2024 | 2 | $10.0m | 0 | — | — |
| Q1 2025 | 0 | — | 0 | — | — |
| Q2 2025 | 0 | — | 0 | — | — |
None reported in Q2 2025.
Holders, Q2 2025
| Manager | Shares | Change |
|---|---|---|
| ENAVATE SCIENCES GP, LLC 3.11% of their portfolio | 3.8m $5.5m | Unchanged |
| 5AM Venture Management, LLC 1.63% of their portfolio | 2.9m $4.2m | Unchanged |
| a16z Capital Management, L.L.C. 0.98% of their portfolio | 2.1m $3.1m | Unchanged |
| HarbourVest Partners LLC 2.02% of their portfolio | 1.3m $1.8m | Unchanged |
| FMR LLC 0.00% of their portfolio | 607.9k $881.5k | Reduced -159.0k |
| VANGUARD GROUP INC 0.00% of their portfolio | 328.9k $476.9k | Added +95.1k |
| Alyeska Investment Group, L.P. 0.00% of their portfolio | 200.0k $290.0k | Unchanged |
| MILLENNIUM MANAGEMENT LLC 0.00% of their portfolio | 133.0k $192.9k | New |
| BlackRock, Inc. 0.00% of their portfolio | 84.2k $122.1k | Reduced -212.0k |
| VICTORY CAPITAL MANAGEMENT INC 0.00% of their portfolio | 83.1k $120.4k | Added +1.3k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 75.2k $109.0k | Reduced -84.4k |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 26.5k $38.4k | Added +14.6k |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 25.0k $36.2k | New |
| Qube Research & Technologies Ltd 0.00% of their portfolio | 14.9k $21.6k | New |
| Verition Fund Management LLC 0.00% of their portfolio | 14.8k $21.4k | New |
| NORTHERN TRUST CORP 0.00% of their portfolio | 14.6k $21.2k | Reduced -42.3k |
| CANTOR FITZGERALD, L. P. 0.00% of their portfolio | 12.3k $17.9k | New |
| UBS Group AG 0.00% of their portfolio | 5.1k $7.4k | Added +1.9k |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 3.8k $5.6k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 1.9k $4.0k | Added +1.5k |
| MORGAN STANLEY 0.00% of their portfolio | 1.7k $2.4k | Reduced -7.3k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 652 $946 | Reduced -2.6k |
| BNP PARIBAS FINANCIAL MARKETS 0.00% of their portfolio | 427 $619 | Added +215 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 238 $345 | Reduced -8.0k |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 119 $173 | Reduced -3.7k |
| NISA INVESTMENT ADVISORS, LLC 0.00% of their portfolio | 101 $146 | Reduced -119 |
| CWM, LLC 0.00% of their portfolio | 68 $0 | Reduced -192 |
| SBI Securities Co., Ltd. 0.00% of their portfolio | 20 $29 | New |
| EverSource Wealth Advisors, LLC 0.00% of their portfolio | 3 $4 | Reduced -13 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. — of their portfolio | 0 $0 | Unchanged |